IL89872A - Use of 2-oxindole-1-carboxamides converted at position 3 to prepare boils to suppress T cell function - Google Patents
Use of 2-oxindole-1-carboxamides converted at position 3 to prepare boils to suppress T cell functionInfo
- Publication number
- IL89872A IL89872A IL8987289A IL8987289A IL89872A IL 89872 A IL89872 A IL 89872A IL 8987289 A IL8987289 A IL 8987289A IL 8987289 A IL8987289 A IL 8987289A IL 89872 A IL89872 A IL 89872A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- pharmaceutically
- acceptable base
- base salt
- formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/181,142 US4853409A (en) | 1988-04-13 | 1988-04-13 | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function |
Publications (2)
Publication Number | Publication Date |
---|---|
IL89872A0 IL89872A0 (en) | 1989-12-15 |
IL89872A true IL89872A (en) | 1994-06-24 |
Family
ID=22663072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL8987289A IL89872A (en) | 1988-04-13 | 1989-04-06 | Use of 2-oxindole-1-carboxamides converted at position 3 to prepare boils to suppress T cell function |
Country Status (17)
Country | Link |
---|---|
US (1) | US4853409A (ko) |
EP (1) | EP0337628B1 (ko) |
JP (1) | JPH01311022A (ko) |
KR (1) | KR920002328B1 (ko) |
AT (1) | ATE89725T1 (ko) |
AU (1) | AU601326B2 (ko) |
CA (1) | CA1324762C (ko) |
DE (1) | DE68906707T2 (ko) |
DK (1) | DK174289A (ko) |
HU (1) | HU204996B (ko) |
IE (1) | IE62751B1 (ko) |
IL (1) | IL89872A (ko) |
MY (1) | MY103872A (ko) |
NZ (1) | NZ228712A (ko) |
PH (1) | PH25857A (ko) |
PT (1) | PT90249B (ko) |
ZA (1) | ZA892622B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006547A (en) * | 1990-03-19 | 1991-04-09 | Pfizer Inc. | Tenidap as an inhibitor of the release of elastase by neutrophils |
US5008283A (en) * | 1990-03-19 | 1991-04-16 | Pfizer Inc. | Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
US5122534A (en) * | 1991-02-08 | 1992-06-16 | Pfizer Inc. | Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides |
DE4111305C2 (de) * | 1991-04-08 | 1994-12-01 | Mack Chem Pharm | Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält |
DE4111306C2 (de) * | 1991-04-08 | 1994-06-01 | Mack Chem Pharm | Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind |
US5298522A (en) * | 1993-01-22 | 1994-03-29 | Pfizer Inc. | 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio |
BR9405661A (pt) * | 1993-01-22 | 1995-11-21 | Pfizer | Sal de lisina de 6-cloro-5-flúor-3-(2-tenoil)-2-oxindole-1-carboxamida |
US5545656A (en) * | 1995-04-05 | 1996-08-13 | Pfizer Inc. | 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease |
BG62359B1 (bg) * | 1995-07-13 | 1999-09-30 | Anormed | N,n-диетил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанаминдималеат |
WO1997022605A1 (en) * | 1995-12-19 | 1997-06-26 | Pfizer Inc. | Stable, long acting salts of indole derivatives for the treatment of joint diseases |
EP0826685A1 (en) * | 1996-08-21 | 1998-03-04 | Pfizer Inc. | Stable, long acting salts of carboxamides for the treatment of joint disease |
WO2006105796A1 (en) * | 2005-04-08 | 2006-10-12 | Leo Pharma A/S | Novel indolinone derivatives |
EP2886541A1 (en) * | 2013-12-19 | 2015-06-24 | Sanofi | Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
DE3413572A1 (de) * | 1984-04-11 | 1985-10-24 | Hoechst Ag, 6230 Frankfurt | Oxindol-verbindungen zur behandlung der epilepsie |
US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
WO1987004618A1 (en) * | 1986-01-30 | 1987-08-13 | University Of Utah | Treatment of bone loss |
RO105052B1 (en) * | 1987-02-02 | 1994-12-01 | Pfizer | Producing process for the crystalline sodium salt, anhydre, of 5-chlorine-3-(2-tenoil)-2-oxindol-1-carboxamide |
-
1988
- 1988-04-13 US US07/181,142 patent/US4853409A/en not_active Expired - Lifetime
-
1989
- 1989-03-28 EP EP89303050A patent/EP0337628B1/en not_active Expired - Lifetime
- 1989-03-28 DE DE8989303050T patent/DE68906707T2/de not_active Expired - Fee Related
- 1989-03-28 AT AT89303050T patent/ATE89725T1/de not_active IP Right Cessation
- 1989-03-31 PH PH38415A patent/PH25857A/en unknown
- 1989-04-06 IL IL8987289A patent/IL89872A/en not_active IP Right Cessation
- 1989-04-08 MY MYPI89000448A patent/MY103872A/en unknown
- 1989-04-10 JP JP1090492A patent/JPH01311022A/ja active Pending
- 1989-04-11 PT PT90249A patent/PT90249B/pt not_active IP Right Cessation
- 1989-04-11 ZA ZA892622A patent/ZA892622B/xx unknown
- 1989-04-11 CA CA000596306A patent/CA1324762C/en not_active Expired - Fee Related
- 1989-04-12 HU HU891754A patent/HU204996B/hu not_active IP Right Cessation
- 1989-04-12 AU AU32712/89A patent/AU601326B2/en not_active Ceased
- 1989-04-12 IE IE117189A patent/IE62751B1/en not_active IP Right Cessation
- 1989-04-12 DK DK174289A patent/DK174289A/da not_active Application Discontinuation
- 1989-04-12 NZ NZ228712A patent/NZ228712A/en unknown
- 1989-04-12 KR KR1019890004822A patent/KR920002328B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE891171L (en) | 1989-10-13 |
DE68906707D1 (de) | 1993-07-01 |
PT90249A (pt) | 1989-11-10 |
IE62751B1 (en) | 1995-02-22 |
IL89872A0 (en) | 1989-12-15 |
KR890015740A (ko) | 1989-11-25 |
ATE89725T1 (de) | 1993-06-15 |
EP0337628B1 (en) | 1993-05-26 |
ZA892622B (en) | 1990-11-28 |
CA1324762C (en) | 1993-11-30 |
AU3271289A (en) | 1989-10-19 |
MY103872A (en) | 1993-09-30 |
DK174289D0 (da) | 1989-04-12 |
PT90249B (pt) | 1994-06-30 |
KR920002328B1 (ko) | 1992-03-21 |
PH25857A (en) | 1991-12-02 |
EP0337628A3 (en) | 1991-01-02 |
HUT52376A (en) | 1990-07-28 |
AU601326B2 (en) | 1990-09-06 |
JPH01311022A (ja) | 1989-12-15 |
US4853409A (en) | 1989-08-01 |
NZ228712A (en) | 1997-02-24 |
DE68906707T2 (de) | 1993-09-16 |
DK174289A (da) | 1989-10-16 |
EP0337628A2 (en) | 1989-10-18 |
HU204996B (en) | 1992-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4853409A (en) | 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function | |
US4794114A (en) | Inhibition of interleukin-1 production by monocytes and/or macrophages | |
US4717716A (en) | Immuno-regulator | |
CA1324761C (en) | 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis | |
KR940011245B1 (ko) | 전혈청 콜레스테롤, ldl 콜레스테롤 및 트리글리세라이드를 저하시키기 위한 테니다프를 함유하는 제약 조성물 | |
KR20010021897A (ko) | 건망증의 예방 또는 치료약 | |
US5006547A (en) | Tenidap as an inhibitor of the release of elastase by neutrophils | |
HRP960341A2 (en) | New methods of using n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) | |
CA2335366A1 (en) | Compositions and methods for treating elevated blood cholesterol | |
EP0425109B1 (en) | 3-Substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis | |
RU2160102C2 (ru) | Применение бензидамина для лечения патологических состояний, вызванных фно | |
IL92586A (en) | History of 5-hydroxy and 5-methoxy-2-aminopyrimidines as inhibitors of interleukin-1 formation | |
CA1162856A (en) | Aldose reductase inhibition by 1-(4-chlorobenzoyl)-5- methoxy-2-methyl-1h-indole-3-acetic acid | |
US5461072A (en) | Use of aryl hydroxyurea compounds for the treatment of atherosclerosis | |
KR960703924A (ko) | 항바이러스제로서 신규한 벤조티오펜 유사체(Novel Benzothiophene Analogs as Antiviral Agents) | |
US4361582A (en) | Aldose reductase inhibition by γ-oxo-8-fluoranthenebutanoic acid | |
NZ235638A (en) | The use of indole derivatives for treating interleukin-1 related disorders | |
CA2156120A1 (en) | 3-substituted-2-oxindoles as inhibitors of viral replication |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |